DEGASi® Plus semi-prep system adapted for the reagent kit manufacturer

credit: Biotech Fluidics

Inline degasser reduces anomalies in reagent dispensing

Biotech Fluidics report how installation of two DEGASi® Plus semi-prep 6-channel degassing systems on a production line, has enabled a diagnostic kit manufacturer to almost eliminate inaccurate reagent dispensing issues.

Original story from Biotech Fluidics.

Dispensing precision is critical to the performance of modern diagnostic kits, where repeatability and accuracy in the amount of reagent dispensed form the basis of reliable results. Collaborating closely with the customer, Biotech Fluidics identified in the reagent kit manufacturing process that chilled solutions warmed up during the dispensing procedure as they moved through the fluidic system - from the bulk supply to the dispensing nozzle.

Fritiof Pontén, CEO of Biotech Fluidics commented “The increase in temperature, as well as negative pressure transient, and bubble nucleation points within the system resulted in outgassing. This unwanted effect led to bubble formation in pumps and check valves, lowering the dispensing precision in the kit manufacture. Such deviation in the dispensed amount of reagent solutions negatively affect the validity, economics, and possibly even the regulatory approval of a product.”

He added “Our implemented solution of continuous inline degassing with Teflon® AF membranes effectively removed dissolved gases from reagent solutions thereby greatly increasing precision and reducing dispensing errors by 77%. Before the installation of the two DEGASI PLUS systems the reagent kit manufacturer observed significant dispensing errors in 2% of all samples. Installation of our in-line degassing systems eliminated this source of dispensing errors.”

The DEGASi® Plus semi-prep degasser is designed to efficiently remove gas bubbles from processes operating at flow rates of 3-6 mL/min. This high-performance inline degasser is equipped with 1-6 chambers with a biocompatible flow path of 925 microliters for both aqueous and organic fluids. For further information on the DEGASi® Plus semi-prep degasser please visit https://biotechfluidics.com/products/degassing-debubbling/degasi/degasi-plus/degasi-plus-semi-prep/

To discuss development of an inline degassing system for your diagnostic kit production line contact Biotech Fluidics on + 46 300 56 91 80 / + 1-612-703-5718 / info@biotechfluidics.com.

Biotech Fluidics is a leading supplier of fluidic system solutions, liquid transfer components, degassing systems, and innovative laboratory technology to instrument developers, manufacturers, and distributors all around the world. The company’s mission is to empower its customers by designing and assembling unique products, being a reliable partner, offering first-class service, in-depth knowledge, and offering advanced technical support for all the items it provides. More information - http://www.biotechfluidics.com


This article is a republished press release from Biotech Fluidics. Note: material may have been edited for length and content. For further information, please contact the cited source. Our press release republishing policy can be accessed here.

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

GreenCooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
Clear sample tubes are shown in a clear tote with red lids in a sample prep robot with a blue and silver industrial lab background.

The crucial role of sample preparation in biotherapy manufacturing

Discover how better sample preparation can unlock improved assay accuracy and analytical results.
A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue